Avanir Relying On PBA Drug Nuedexta For Success
This article was originally published in The Pink Sheet Daily
Executive Summary
Approved last year for pseudobulbar affect and gradually gaining sales and formulary adoption, Nuedexta will be studied in additional CNS indications.